Form 4: Labcorp CEO Adam Schechter Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Adam Schechter, President & CEO of Labcorp Holdings Inc., sold 6,105 shares of common stock at $248.73 per share on May 12, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Adam H. Schechter, the President & CEO of Labcorp Holdings Inc., sold 6,105 shares of the company's common stock on May 12, 2025.
- The sale was executed at a price of $248.73 per share.
- The transaction was conducted under a pre-arranged trading plan that complies with Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- Following the sale, Schechter directly owns 98,962 shares of Labcorp common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding an insider stock sale. The sentiment is neutral as it simply reports a transaction.
Industry Context
Sales by insiders are a common occurrence and are often pre-planned to avoid accusations of trading on inside information. The market will likely interpret this sale in the context of Schechter's overall holdings and the company's performance.
Stakeholder Impact
- The sale of shares by the CEO could be perceived negatively by some shareholders, although the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 05/12/2025 | Date of stock sale transaction |
| 05/13/2025 | Date of signature on the Form 4 filing |
Keywords
Labcorp, Adam Schechter, stock sale, Form 4, 10b5-1 plan, insider trading, LH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.